Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
206.6 USD | -0.37% | -2.37% | -12.61% |
06-28 | Argus Downgrades Charles River Laboratories International to Hold From Buy | MT |
06-25 | Charles River Laboratories, Gates Institute Collaborate on Lentiviral Vector Manufacturing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.61% | 10.64B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-8.23% | 9.12B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Transcript : Charles River Laboratories International, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 01